Skip to content

Progyny PGNY Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

Organon logo
OrganonOGN
$81M
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
-$57K-1,800%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
-$573K-267%

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.11B-27.1%
Enterprise value$2B-29.6%
P/E31.1×-23.9×
P/S1.6×-0.8×

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfPropertyPlantEquipment.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's gain/loss on asset sales?
Progyny (PGNY) reported gain/loss on asset sales of -$52K in Q1 2026.
How has Progyny's gain/loss on asset sales changed year-over-year?
Progyny's gain/loss on asset sales increased by 34.2% year-over-year, from -$79K to -$52K.
What does gain/loss on asset sales mean?
Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.